Académique Documents
Professionnel Documents
Culture Documents
Arrhythmias
Bradycardia Tachycardia 1st degree AV block 2nd degree AV block 3rd degree AV block
Premature Ventricular Complex (PVC) Atrial Fibrillation Ventricular Tachycardia Ventricular Fibrillation
Bradycardia
conventional: < 60 beats/min More useful: < 50 beats/min
Tachycardia
conventional > 100 beats/min More useful: > 90 beats/min
AP Conduction of PVC
Initiation site
Atrial Fibrillation
If persistent rhythm:
control ventricular rate (verapamil) anticoagulant therapy
Ventricular Tachycardia
Large, sustained reduction of arterial pressure
Treatment:
Ventricular Fibrillation
Chaotic ventricular electrical activity which causes the heart to lose the ability to function as a pump.
Treatment: defibrillation
Defibrillation
Arrhythmia Mechanisms
Pathological Conditions
Ischemia Intracellular Ca2+ overload Stress: adrenergic stimulation Genetic defects- especially in ion channels Anatomic defects Drug effects
Arrhythmia Mechanisms
Single cell mechanisms Multi-cell mechanisms
Note: Most arrhythmias originate as inappropriate electrical activity in ventricular and Purkinje cells.
Action potential
-50
Congenital long QT
200 msec
A Multi-Cell Mechanism
0 0
-50
200 msec
Purkinje fibers
20 msec
-50
A
200 msec
Ventricular Muscle
Conduction Times
250 msec
-50
200 msec
Long QT Syndrome
From: Ion Channels and Disease F.M. Ashcroft. Academic Press 2000
LQT Genetics
Type Gene
LQT1 LQT2 LQT3 LQT4 KCNH2 (hERG) SCN5A unknown
Chromosome Comment
Trigger: Stress Trigger: Startle (e.g. sudden noise) Trigger: Sleep Variants found in one large family with long QT. Precise location of gene is unknown. Associated with Jervell and LangeNielsen syndrome (congenital deafness) Triggers: drugs, exercise Associated with Andersen syndrome 7 3 4
KCNQ1 (KvLQT1) 11
21 21 17
Summary
Normal cardiac function relies on channels and anatomy Arrhythmias involve ion channels in a pathological setting Most antiarrhythmic drugs involve ion channels
Antiarrhythmic Drugs
Amiodarone
Verapamil